B O O K - American College of Rheumatology

Session Overview:
We are witnessing a rapid increase in the use of web-based tools
by health care practitioners and educators to facilitate clinical
activities and instructional sessions. The ease of use and speed
of deployment makes Twitter, blogs, and wikis effective forums
for communication. However, determining the most appropriate
format for the specific needs of your practice, lecture, or class
can be overwhelming. This interactive session will review key
features for evaluating technological formats, demonstrate the
use of Twitter, blogs, and wikis, and discuss how practitioners
and educators have specifically used these technologies.
Upon completion of this session, participants should be able to:
• identify features of web-based tools such as content
integration and discussion forums for evaluating technological
formats
• describe how to create Twitter accounts, blogs, and wikis
• discuss how Twitter, blogs, and wikis can enhance clinical
practice and instructional sessions
ACR Basic Science Symposia
4:30 - 6:00 PM
B402
A Critical Role for Lipid Metabolism in the Interplay
between Atherosclerosis and Autoimmune Disorders
R
Moderators: Radjesh Bisoendial, MD, PhD; Academic Medical
Center University of Amsterdam; Amsterdam, Netherlands
Zoltan Szekanecz, MD, PhD, DSC; University of Debrecen Medical
Center; Debrecen, Hungary
4:30 PM
High-Density Lipoprotein Regulates Cellular Immune Responses
via Adenosine Triphosphate-binding Cassette
Alan Tall, MD; Columbia University; New York, NY
5:00 PM
The Dual Function of High Density Lipoproteins to Suppress
Inflammatory Activity and Protect Against Heart Disease
in Rheumatoid Arthrititis and Other Immune-mediated
Inflammatory Diseases
Kerry-Anne Rye, PhD; The Heart Research Institute; Newtown,
Sydney, New South Wales, Australia
5:30 PM
Liver X Receptor Signaling at the Crossroads Between Immunity
and Cholesterol Homeostasis
Uwe JF. Tietge, MD; University Medical Center Groningen;
Groningen, Netherlands
Session Overview:
Cardiovascular disease represents a major cause of increased
morbidity and mortality in various immune-mediated
inflammatory disorders. This symposium will provide insight into
the factors involved in the increased cardiovascular risk and the
underlying mechanisms.
Upon completion of this session, participants should be able to:
• identify the key players that integrate metabolic and
inflammatory signaling in increased cardiovascular disease
among individuals with immune-mediated inflammatory
diseases
• define the basics of the pathogenic mechanisms that drive
atherosclerosis in immune-mediated inflammatory diseases
B313
Molecular Mechanisms of Ocular Inflammation R
Moderators: James T. Rosenbaum, MD; Oregon Health & Science
University; Portland, OR
Holly L. Rosenzweig, PhD; Oregon Health & Science University;
Portland, OR
4:30 PM
Is Macular Degeneration, the Leading Cause of Acquired
Blindness, an Autoimmune Disease?
Jayakrishna Ambati, MD; University of Kentucky; Lexington, KY
5:00 PM
The Role of IL-17 in Autoimmune Uveitis
Rachel Caspi, PhD; National Eye Insitute; Bethesda, MD
5:30 PM
Are Biologic Therapies Indicated to Treat Inflammatory Eye
Diseases?
James T. Rosenbaum, MD; Oregon Health & Science University;
Portland, OR
Session Overview:
The majority of rheumatologic diseases include a component of
ocular inflammation. A better understanding of the pathogenesis
of ocular inflammation will lead to insights into inflammation in
other organs involved in rheumatic diseases.
Upon completion of this session, participants should be able to:
• identify the relative contributions of TH1, TH2, and TH17 T cell
subsets in an animal model of uveitis
• describe the role of growth factors, toll receptors,
chemokines, and monocytes in the pathogenesis of macular
degeneration
• define the role of biologic therapies in the treatment of
inflammatory eye diseases
ACR Clinical Symposia
4:30 - 6:00 PM
Sidney J. Marcus Auditorium
New Development in Systemic Juvenile Idiopathic
Arthritis - From Bench to Effective Interventions P
PS
Moderators: Alexei A. Grom, MD; Children’s Hospital Medical
Center; Cincinnati, OH
Sampath Prahalad, MD, MSc; Emory Children’s Center; Atlanta,
GA
4:30 PM
Introduction: Systemic Juvenile Idiopathic Arthritis as an
Autoinflammatory Syndrom
Sampath Prahalad, MD, MSc; Emory Children’s Center; Atlanta,
GA
4:40 PM
IL-1 and Systemic Juvenile Idiopathic Arthritis
Norman T. Ilowite, MD; Children’s Hospital Montefiore; Bronx,
NY
2010 Program Book 121
wednesday